DK0939648T3 - Rotavirusvaccineformuleringer - Google Patents

Rotavirusvaccineformuleringer

Info

Publication number
DK0939648T3
DK0939648T3 DK97944477T DK97944477T DK0939648T3 DK 0939648 T3 DK0939648 T3 DK 0939648T3 DK 97944477 T DK97944477 T DK 97944477T DK 97944477 T DK97944477 T DK 97944477T DK 0939648 T3 DK0939648 T3 DK 0939648T3
Authority
DK
Denmark
Prior art keywords
vaccine formulations
rotavirus vaccine
rotavirus
formulations
vaccines
Prior art date
Application number
DK97944477T
Other languages
English (en)
Inventor
Carl J Burke
David B Volkin
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9621991.0A external-priority patent/GB9621991D0/en
Priority claimed from GBGB9714333.3A external-priority patent/GB9714333D0/en
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Application granted granted Critical
Publication of DK0939648T3 publication Critical patent/DK0939648T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/15—Reoviridae, e.g. calf diarrhea virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12311—Rotavirus, e.g. rotavirus A
    • C12N2720/12334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
DK97944477T 1996-09-26 1997-09-26 Rotavirusvaccineformuleringer DK0939648T3 (da)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US2675496P 1996-09-26 1996-09-26
GBGB9621991.0A GB9621991D0 (en) 1996-10-22 1996-10-22 Rotavirus vaccine formulations
US4676097P 1997-05-16 1997-05-16
GBGB9714333.3A GB9714333D0 (en) 1997-07-07 1997-07-07 Rotavirus vaccine formulations
PCT/US1997/017274 WO1998013065A1 (en) 1996-09-26 1997-09-26 Rotavirus vaccine formulations

Publications (1)

Publication Number Publication Date
DK0939648T3 true DK0939648T3 (da) 2008-02-11

Family

ID=27451542

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97944477T DK0939648T3 (da) 1996-09-26 1997-09-26 Rotavirusvaccineformuleringer

Country Status (10)

Country Link
EP (2) EP1891968A3 (da)
JP (1) JP4653262B2 (da)
AT (1) ATE377428T1 (da)
AU (1) AU739916B2 (da)
CA (1) CA2266486C (da)
DE (1) DE69738271T2 (da)
DK (1) DK0939648T3 (da)
ES (1) ES2294801T3 (da)
PT (1) PT939648E (da)
WO (1) WO1998013065A1 (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6403098B1 (en) * 1996-09-26 2002-06-11 Merck & Co., Inc. Rotavirus vaccine formulations
KR20010093290A (ko) * 1999-02-05 2001-10-27 폴락 돈나 엘. 사람 파필로마바이러스 백신 제제
FR2791895B1 (fr) * 1999-03-23 2001-06-15 Pasteur Merieux Serums Vacc Utilisation de trehalose pour stabiliser un vaccin liquide
US6436993B1 (en) 1999-07-13 2002-08-20 The Salk Institute For Biological Studies Use of RAR antagonists as modulators of hormone mediated processes
SK287261B6 (sk) * 1999-08-17 2010-04-07 Smithkline Beecham Biologicals S.A. Oslabená ľudská rotavírusová populácia, spôsob jej výroby, vakcínový prostriedok s jej obsahom a jej použitie
GB0503337D0 (en) 2005-02-17 2005-03-23 Glaxosmithkline Biolog Sa Compositions
AU2013224715B2 (en) * 2007-03-22 2015-10-08 The Regents Of The University Of Colorado Method of preparing an immunologically-active adjuvant-bound dried vaccine composition
EP2829282B1 (en) * 2007-03-22 2017-10-25 The Regents of The University of Colorado, A Body Corporate Method of preparing an immunologically-active adjuvant-bound dried vaccine composition
CN103269716B (zh) 2010-12-02 2015-05-27 昂科利蒂克斯生物科技公司 冻干病毒制剂
WO2012075379A2 (en) 2010-12-02 2012-06-07 Oncolytics Biotech Inc. Liquid viral formulations
US12447127B2 (en) 2011-05-17 2025-10-21 The Regents Of The University Of Colorado, A Body Corporate Thermostable vaccine compositions and methods of preparing the same
US20130309273A1 (en) 2012-05-17 2013-11-21 Kimberly Hassett Thermostable Vaccine Compositions and Methods of Preparing Same
KR102049988B1 (ko) * 2011-06-24 2019-11-28 머크 샤프 앤드 돔 코포레이션 알루미늄 아주반트를 포함하는 hpv 백신 제제 및 그의 제조 방법
US20140356396A1 (en) * 2011-08-25 2014-12-04 Brian L. Pulliam Rotavirus preparations with excess calcium ions and high viscosities that ensure viability at elevated temperatures
BR112014020930A2 (pt) * 2012-03-05 2017-06-27 De Staat Der Nederlanden Vert Door De Mini Van Vws Miniie Van Volksgezondheid Welzijn En Sport método para produzir uma formulação seca de um agente biofármaco, e, formulação de um agente biofármaco
US10532093B2 (en) * 2014-07-18 2020-01-14 Mds Wellcome Trust Hilleman Laboratories Pvt. Ltd. Thermostable freeze dried rotavirus vaccine formulation and process to prepare thereof
EP3389786A4 (en) * 2015-12-18 2019-08-21 Merck Sharp & Dohme Corp. HEAT-RESISTANT ROTAVIRUS VACCINE FORMULATIONS AND METHOD FOR USE THEREOF
MA44557B1 (fr) 2016-06-16 2021-11-30 Bharat Biotech Int Ltd Vaccin contre le rotavirus sans tampon, stable en milieu acide, et d'un faible volume de dose à administrer
AU2020328159A1 (en) * 2019-08-09 2022-01-27 Valneva Se Single shot Chikungunya virus vaccine
PH12021553186A1 (en) * 2019-08-09 2022-12-12 Valneva Se Chikungunya vaccine formulations

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2505657A1 (fr) * 1981-05-13 1982-11-19 Pasteur Institut Perfectionnements apportes aux agents de stabilisation de virus vivants pour la preparation de vaccins, et vaccins stabilises contenant lesdits agents de stabilisation
US4636385A (en) * 1985-02-15 1987-01-13 The Wistar Institute Of Anatomy & Biology Vaccine, method for its preparation, and use thereof in vaccinating humans against rotavirus infection
US5626851A (en) * 1987-11-30 1997-05-06 The Wistar Institute Of Anatomy And Biology Rotavirus reassortant vaccine
ES2122973T3 (es) * 1990-07-26 1999-01-01 Wistar Inst Vacuna de recombinante de rotavirus.
WO1996001651A1 (en) * 1994-07-11 1996-01-25 The Government Of The United States Of America, Represented By The Department Of Health And Human Services Attenuated human rotavirus vaccine

Also Published As

Publication number Publication date
AU4596397A (en) 1998-04-17
DE69738271D1 (de) 2007-12-20
CA2266486A1 (en) 1998-04-02
CA2266486C (en) 2007-09-25
EP0939648A1 (en) 1999-09-08
ES2294801T3 (es) 2008-04-01
WO1998013065A1 (en) 1998-04-02
AU739916B2 (en) 2001-10-25
PT939648E (pt) 2008-01-11
JP4653262B2 (ja) 2011-03-16
EP1891968A2 (en) 2008-02-27
EP1891968A3 (en) 2008-09-03
ATE377428T1 (de) 2007-11-15
JP2002500622A (ja) 2002-01-08
EP0939648B1 (en) 2007-11-07
DE69738271T2 (de) 2008-08-28

Similar Documents

Publication Publication Date Title
ATE377428T1 (de) Rotavirus-impfstoff
DK1021547T3 (da) Vaccineformuleringer indeholdende papillomviruskapsomer og fremgangsmåder til anvendelse heraf
PT758248E (pt) Formulacoes para o factor ix
DE69943359D1 (de) Tumorassoziierte Antigenderivate der Mage-Familie, zur Herstellung von Fusionsproteinen mit T-Helper Epitope und Zusammensetzungen zur Impfung
IT8920207A0 (it) Procedimento per la preparazione di perfluoropolieteri perossidici.
ES2089316T3 (es) Agente viral asociado con la enfermedad porcina misteriosa (mystery swine desease).
DK0745387T3 (da) Adjuvanser til virale vacciner
NO2010011I1 (no) Levende svekket humant rotavirus stamme Rix 4414 (Rotavirus vaksine)
DK1047446T3 (da) Vaccinesammensætning til Herpes Simplex virus og fremgangsmåder til anvendelser deraf
PT1206189E (pt) Formulacoes para vacinas de rotavirus
DZ2283A1 (fr) Composition de vaccin.
DK0765333T3 (da) Quillajasaponinadjuvans og vaccineformulering, der indeholder denne
FI972054A0 (fi) Immunogeenisiä koostumuksia
IL98262A (en) Chromone derivatives and pharmaceutical compositions containing them
BR9704879A (pt) Composição de vacina e uso de um vírus cav vivo
FI925032A7 (fi) Rokotekoostumukset
MY127474A (en) Naphthyl compounds, intermediates, compositions, and methods of use
PT894500E (pt) Vacina para streptococcus equi
DK0493575T3 (da) Vaccine af reassortant rotavirus
DE69830156D1 (de) Zusammensetzungen zur immunverstärkung von impfstoffen
MX9202293A (es) Composicion de vacuna no-irritante.
EP0563288A4 (en) Immunopotentiation of vaccines, particularly swine pleuropneumonia vaccines
GB9621991D0 (en) Rotavirus vaccine formulations
ZA978586B (en) Rotavirus vaccine formulations.
LV10395A (lv) Bezsapju vakcinas sastavs